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Clinical Evaluation of Eastman Kodak's Ektachem 400 Analyzer

Cheryl L Kadinger and Richard T. O'KelI
We evaluated the performance of the Kodak Ektachem 400 Analyzer in a 16-week clinical trial. We assessed four potentiometric tests and nine colorimetric tests for precision and correlation with results obtained some other commonly used instruments (Technicon SMA II and C800 System, Du Pont aca II, and Baker CentrifiChem). The comparison was favorable for all tests except albumin, sodium, and carbon dioxide. The reagents are stable. Little refrigerator storage space is needed. The computer system and the modular component design of the Ektachem 400 Analyzer make operation, troubleshooting, and preventive maintenance relatively easy. we stored the amylase cartridges in the freezer and, to obviate condensation of moisture, they were allowedto sit unopenedat room temperature for 1 h before being placed in the analyzer. All other slides were stored at 4#{176}C and were allowed to sit for 30 mm at room temperature just before use. Each cartridge of slides, once in the analyzer, was under controlled conditions of humidity and temperature, and were stable for no longer than three and five days for the potentiometric and colonmetric tests, respectively.
AdditIonalKeyphrases
The reference fluid used with the potentiometric slides was stable for 8 h after opening.
Sample preparation.
For analysis in the Ektachem 400
Analyzer, 10 L of sample is used per test, with a minimum dead volume (the amount of specimen in the cup not available for sampling) of 60 L recommended. Samples are pipetted into 1-mL cups, which are immediately covered with a pierceable cap, to minimize evaporation and prevent contamination. The serum samples were from hospitalized patients and outpatients, and the specimens selected covered a wide range of analyte concentration. Specimens analyzed for bilirubin were from infants younger than 10 days.
Blood was sampled into Evacuated Blood-Collection
Tubes or Corvac Integrated Serum Separation Tubes (Monojest: Sherwood Medical Industries,
St. Louis, MO 63103).
Blood Serum Filters (Glasrock Plastics, Fairburn, GA 30213) were used to separate serum from the clot in those tubes with no barrier (i.e., non-Corvac tubes) and when visible fibrin was present in Corvac tubes. Spinal fluid specimens submitted for routine analysis were assayed for glucose without delay. First morning urine specimens for glucose determination were collected from patients in the metabolic unit of our hospital; 24-h urine specimens routinely collected for creatinine determinations were used for urea nitrogen assay. All urine specimens were stored at 4#{176}C for no longer than seven days before analysis. All fluid specimens used in the instrument comparison study were analyzed in the comparison instrument and the Ektachem 400 Analyzer within 2 h of each other.
Evaluation of precision.
We used lyophilized commercial control sera, reconstituted daily with class A volumetric pipettes. The protocol, consisting of one run of high, medium, and low analyte concentrations for each analyte, was repeated twice in the morning and twice in the afternoon. 
Results
Colorimetric Tests
The within-nm CVs for all the colorimetric tests, and the day-to-day CVs for glucose, calcium, uric acid, total protein, and triglyceride were <3%. The CVs for the low-concentration control for urea nitrogen, neonatal bilirubin, and amylase were 4.2%, 6.0%, and 4.7%, respectively; the CV for the higher concentrations was <3%. The CVs for all assays were <3% within run for control material supplied by KOdak. Table 2 and Figures 1,2, and 3 . spinal fluid glucose (t = 6.1). The instruments compared for these tests gave means that were statistically different.
Potentiometric Tests
Both within-nm and day-to-day CVs for sodium and chloride were <2%. The within-nm CV for potassium was <2% and for CO2 <4%. The day-to-day CVs were <4% for potassium and 6% for carbon dioxide. Day-to-day CVs were calculated from no fewer than 23 and no more than 100 values. Technicon's C800 system and SMA II were more precise than the Ektachem 400 Analyzer (F-test, p = 0.05), for both analyte concentrationsof sodium. The SMAll was more precise than the Ektachem 400 Analyzer for potassi-SMA II (lecknicon) system was more precise at the high analyte concentration, but not significantly different at the low concentration.The Ektachem 400 Analyzer was more precise than the SMAll for both concentrations of control and than the C800 system at the upper analyte concentration for chloride,with no significant difference in CV for the lower concentration.
The CVs for both the C800 system and the SMA II were better at the high concentration than the 10.
6.
2.
10. 0 SMA II (Technicori) Survey, 1979, using the mean values closest to our controls) and (or) the slopes differing by >10% from unity. Results of the F-test indicated evaluation by Student's t-test to be invalid for the electrolyte tests.
Discussion
The new technology in Eastman Kodak's clinical chemistry slide is an interesting advance in the area of drychemistry analysis. The reagents being dry and contained, there is no waste and very little clean up. The amount of storage space needed for the slides is much less than the space needed for reagents for continuous-flow analysis and other automated chemistry methods. The slides were stable when the storage protocols specified by Eastman Kodak were followed. The variability between cartridges and lot numbers was within specifications.
The nature of the slide's matrix (reagent layers) make the slides sensitive to fluids with viscosity and buffering capacities different from human serum. For this reason primary standards cannot be used for calibration. When an analyte concentration exceeds the linearity of the analyzer, each chemistry has specific protocols for dilution that must be followed.
A 60-jL deadvolume was recommended by the manufacturer, but we found with the analyzer we tested that small (30-pL) samplescouldbe analyzed.
The Ektachem 400 Analyzer is as simple to operateasthe aca II, and requires minimal daily and monthly maintenance, which can be easily performed by the operator. The The samples are processed individually, each with its own disposable sampling tip, so there is no carryover. The presence of fibrin in a particular sample will not cause adverse affects to other samples being processed, unlike continuous-flow automation. An error message will indicate the sample was not aspirated and no result will be reported. The sample size is small (10 pL per test plus 60 iL dead space), allowing more tests to be done on a limited amount of serum than is the case for other instruments. Eastman Kodak provided excellent training on the Ektachem 400 Analyzer for both routine operation and troubleshooting maintenance. Technical assistance by them was readily available throughout the test.
